What are the initial side effects of Mounjaro, and how long do they last?

Which side effects show up most often when you first start Mounjaro?

Nausea is the one people mention most — a low-grade unsettled feeling that tends to be worst in the day or two after each injection. Diarrhoea and constipation can both occur, sometimes alternating. Burping, bloating and acid reflux are also common, particularly after meals. Fatigue, mild headaches and dizziness appear in a smaller proportion of people but are well-documented in the prescribing information.

The reason so many of these effects are gastrointestinal comes down to how tirzepatide works. It activates both GIP and GLP-1 receptors, which slows the rate at which the stomach empties. That slowing is part of what reduces appetite, but it can make the digestive system feel sluggish or unsettled while it adapts. The full Mounjaro overview on this site explains the dual-receptor mechanism if you want the wider picture.

For the majority of people, these early symptoms are mild to moderate and resolve within one to two weeks of starting each dose. Eating smaller portions, avoiding fatty or rich food around injection day, and staying well hydrated all help. A question our prescribers hear most weeks: whether to delay moving to the next dose because of ongoing nausea. The right answer depends on your individual pattern, which is exactly the kind of thing covered in a clinical review, not something a general article can settle for you.

Injection-site reactions (localised redness, tenderness or itching where the pen was used) are also worth knowing about. Rotating between your abdomen, thigh and upper arm each week is the standard way to reduce them. For more on what the injection experience itself involves, the injection-specific side effects page goes into further detail.

Do side effects get worse with each dose increase?

It is common for a milder version of the first-week experience to return each time the dose steps up. Mounjaro's licensed starting dose is 2.5 mg, its job is to let the body adapt gradually before the therapeutic doses begin. As treatment progresses through 5 mg, 7.5 mg and beyond, the same settling-in process can repeat, though many people find each new adjustment easier than the first.

The 5 mg side-effect guide covers what patients typically notice at that specific step. The pattern of transient GI symptoms on dose escalation is well established in the clinical trial data that supported Mounjaro's UK licensing, and the NHS patient information reflects this.

A small number of people find side effects persist beyond the first two weeks or become hard to manage. That is a signal to speak with your prescriber about whether the current dose is right for you, rather than pushing through discomfort alone. If you are finding side effects particularly uncomfortable, our support team is available seven days a week.

There is also a subset of people who experience very few side effects from the outset. The page on starting Mounjaro with no noticeable side effects addresses why that happens and what it means for treatment.

When do Mounjaro's initial side effects need urgent medical attention?

Most early side effects are uncomfortable but not dangerous. A few, though, are warning signs that need prompt action rather than watchful waiting.

Pancreatitis is an infrequent but serious risk with GLP-1-based medicines. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting this. The symptom to act on is severe stomach pain that does not ease and radiates through to the back, with or without vomiting. If that happens, stop the injection and get medical help the same day, do not wait to see whether it settles.

Other symptoms that warrant medical contact rather than home management include signs of a serious allergic reaction (facial swelling, difficulty breathing, a widespread rash), significant dehydration from persistent vomiting or diarrhoea, and sudden changes to vision. Gallbladder problems, including gallstones, have been reported with this class of medicine and can present as upper-right abdominal pain.

Mood changes are worth knowing about too. If you notice low mood, unusual anxiety or any thoughts of self-harm after starting treatment, speak to a doctor promptly. It is not established as a common effect, but it is something your care team should know about.

For a broader picture of side effects beyond the initial period, the complete Mounjaro side effects guide covers the full licensed profile. Sleep disruption and insomnia are occasionally reported; the tirzepatide and insomnia page addresses that specifically.

How does knowing the side effects shape the consultation at nume?

Understanding what to expect from the first few weeks is part of what our prescribers work through with every patient. The free consultation is not a box-ticking exercise, it is a genuine clinical review of whether Mounjaro is appropriate for you, which includes your history of GI conditions, any medicines you are already taking, and factors that might affect how you tolerate the starting dose.

Prescribing decisions are made by a GPhC-registered Independent Prescriber, personally, on the same day your consultation is submitted. If treatment is clinically suitable, it is dispatched the same day for free tracked delivery by DPD the next working day. If you have questions about whether your health history affects suitability, our FAQs page covers the most common ones, or you can find out more about how nume approaches clinical safety.

Any suspected side effects during treatment can also be reported to the MHRA via the Yellow Card scheme, this applies whether you're on a private prescription or an NHS one, and it is one of the ways post-market safety data is gathered for newer medicines. The guide on managing side effects while on Mounjaro has practical tips for the weeks after your first pen arrives.